Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S

Release Summary

FDA accepts for review a supplemental new drug application to expand labeling of abilify maintena® (aripiprazole) for the treatment of bipolar i disorder

Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S